Coronary Artery Disease
-
Publication Venue For
- Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: Insights from the CHAMPION percutaneous coronary intervention trial. 24:321-327. 2013
- Beta-blockers and statins are individually associated with reduced mortality in patients undergoing noncardiac, nonvascular surgery.. 18:67-72. 2007
- A meta-analysis of safety and effectiveness of perioperative beta-blocker use for the prevention of cardiac events in different types of noncardiac surgery.. 17:173-179. 2006
- Late gadolinium cardiovascular magnetic resonance in the assessment of myocardial viability.. 16:365-372. 2005
- Distinct mouse coronary anatomy and myocardial infarction consequent to ligation.. 16:41-44. 2005
- The role of platelet receptors and adhesion molecules in coronary artery disease.. 14:65-79. 2003
- Measurement of myocardial perfusion by contrast echocardiography: application in the operating room.. 11:227-234. 2000
- Coronary intervention and glycoprotein IIb/IIIa integrin blockade.. 10:553-560. 1999
- Nitric oxide in the cardiovascular system. 10:273-276. 1999
- Increased baseline levels of platelet P-selectin, and platelet-endothelial cell adhesion molecule-1 in patients with acute myocardial infarction as predictors of unsuccessful thrombolysis.. 9:451-456. 1998
- Outcomes of diabetic patients following acute myocardial infarction: a review of the major thrombolytic trials.. 7:732-743. 1996
- How magnesium therapy may influence clinical outcome in acute myocardial infarction: review of potential mechanisms.. 7:364-370. 1996
- The use of magnesium in the treatment of patients with acute myocardial infarction. 7:339-340. 1996
- Magnesium in acute myocardial infarction.. 6:831-837. 1995
- Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction.. 5:929-936. 1994
- Randomized evaluation of coronary angioplasty for early TIMI 2 flow after thrombolytic therapy for the treatment of acute myocardial infarction: A new look at an old study. 5:611-615. 1994
- Randomized evaluation of coronary angioplasty for early TIMI 2 flow after thrombolytic therapy for the treatment of acute myocardial infarction: a new look at an old study. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.. 5:611-615. 1994
- The role of angioplasty after failed thrombolysis for acute myocardial infarction.. 5:392-398. 1994
- The role of angioplasty after successful thrombolysis for acute myocardial infarction.. 5:399-406. 1994
- An analysis of the cause of early mortality after administration of thrombolytic therapy. The Thrombolysis Angioplasty in Myocardial Infarction Study Group.. 4:957-964. 1993
- Baseline characteristics and therapeutic goals in the New Approaches to Coronary Intervention (NACI) registry.. 4:1013-1022. 1993
- Cellular and molecular mechanisms of coronary artery restenosis.. 4:254-259. 1993
- Safety and antiplatelet effect of murine monoclonal antibody 7E3 Fab directed against platelet glycoprotein IIb/IIIa in patients undergoing elective coronary angioplasty.. 4:167-175. 1993
- Diagnosis and management of ischemic mitral regurgitation with the use of transesophageal echocardiography. 3:377-381. 1992
- Why are large-scale trials needed?. 3:92-95. 1992
- Diatrizoate-containing contrast media inhibit platelet aggregation by disrupting fibrinogen binding. 2:389-396. 1991
- Development of atherosclerotic-like lesions in the sand rat (Psammomys obesus). 1:469-476. 1990
- Thrombolytic therapy: overview of clinical trials. 1:23-33. 1990
- Adverse reactions to protamine.. 4:420-425. 1993